Our Catalog
Third-party verified. Batch 2026/02. All purity data independently confirmed by Waiida Testing Technologies.
Triple GIP/GLP-1/Glucagon receptor agonist. Independently verified at 99.58–99.81% across all vial sizes.
Human Growth Hormone, verified 191AA sequence. Tested at 98.15–98.44% purity. Batch H/2026/02.
Long R3 Insulin-like Growth Factor. Highest-spec 100mcg vials verified at 99.73% purity. Premium grade.
Selective GHRP with minimal cortisol and prolactin response. Verified at 99.77–99.81%. Ideal pairing with CJC-1295.
GHRH analogue with Drug Affinity Complex for extended half-life. Verified at 99.71–99.78% across both vial sizes.
Body Protection Compound — 15 amino acid partial sequence of body protection compound. Verified at 99.66–99.80%.
Copper peptide tripeptide-1. Verified at 99.68–99.71% purity. Available in 50mg vials for extended protocols.
BPC-157 (10mg) + GHK-Cu (50mg) + TB-500 (10mg) — 70mg premium compound blend. COA-verified total purity 99.77%.
Synthetic analogue of alpha-MSH. Binds melanocortin receptors MC1R and MC4R. 10mg lyophilized powder vial.
0.9% benzyl alcohol sterile water for reconstitution. 3mL multi-use vials compatible with all lyophilized peptide compounds. USP-grade.